Jonathan Gardner - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jonathan Gardner's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jonathan Gardner
Verified
Senior Reporter, BioPharma Dive
Charlottesville
Beats
French Politics Global Affairs Finance and Business. North-Africa
Energy, environment
Content
By Jonathan Gardner Verified| BioPharma Dive Verified Eli Lilly’s weight loss pill orforglipron succeeded in a Phase 3 clinical trial in diabetes, helping study participants control their blood sugar while hinting at weight loss that might be comparable to injectable obesity medicines. Enrollees in the 40-week trial saw their blood sugar levels reduced by up to 1.6 percentage points, with 65% achieving healthy levels, the company said Thursday.
By Jonathan Gardner Verified| BioPharma Dive Verified Pfizer is scrapping another obesity pill, announcing Monday it will stop testing an experimental therapy called danuglipron after uncovering a case of possible liver damage in one study participant. The announcement marks the second time Pfizer has given up on an oral weight loss medicine since 2023 and is its latest setback in obesity, a lucrative market it seeks to break into.
By Jonathan Gardner Verified| BioPharma Dive Verified Eli Lilly’s weight loss pill orforglipron succeeded in a Phase 3 clinical trial in diabetes, helping study participants control their blood sugar while hinting at weight loss that might be comparable to injectable obesity medicines. Enrollees in the 40-week trial saw their blood sugar levels reduced by up to 1.6 percentage points, with 65% achieving healthy levels, the company said Thursday.
Company Info
BioPharma Dive
Banking Dive is a prominent online publication dedicated to the banking industry. It offers in-depth journalism and analysis, providing valuable insights into the latest news, trends, and regulatory changes affecting the sector. As part of Industry Dive, which has merged with TechTarget's technology websites and Informa Tech, Banking Dive has expanded its editorial reach significantly. The platform features a variety of services, including detailed news coverage, a newsletter for subscribers, and deep dive articles that explore specific topics such as regulations and technology's role in banking. Banking Dive caters to professionals in the banking sector, including executives, policymakers, and financial analysts, delivering reliable information to help them navigate the evolving landscape of the industry.
Washington, District of Columbia, United States
+1 202-331-2480